Levaquin 750MG Injectable Recalled Due to Lack of Sterility Assurance
Sentara Infusion Services is recalling 14 bags of Levaquin 750MG injectable antibiotic dispensed nationwide due to lack of sterility assurance. The product was distributed to patients for home infusion pump use.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for injectable antibiotic with lack of sterility assurance. No illnesses or injuries have been reported. Classified as High due to risk-of-harm from non-sterile injectable medication without reported injury.
Plain-English summary
Sentara Infusion Services is recalling 14 bags of Levaquin 750MG IN D5W, an injectable antibiotic medication, because the product may lack adequate sterility assurance. This injectable formulation is designed to be administered to patients via home infusion pump.
The affected product was dispensed nationwide to patients. Based on the Beyond Use Date of December 24-31, 2022, the recalled bags may still be in use.
Patients who received this product should contact their healthcare provider or Sentara Home Infusion Pharmacy Services (535 Independence Parkway, Suite 300, Chesapeake, VA 23320) immediately. Do not use the product if you still have it; return unused portions to your pharmacy or physician.
The recalled product
- Product
- Levaquin 750MG IN D5W 150ML, antibiotic, Rx Only, use with home pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,
- Manufacturer
- Sentara Infusion Services
- Category
- Drug — Injectable Antibiotic
- Hazard
- contamination
- sterility-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Beyond Use Date: December 24-31
- 2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27